Medicine and Dentistry
Neoplasm
100%
Clear Cell Renal Cell Carcinoma
95%
Bladder
82%
Percutaneous Nephrolithotomy
59%
Prostate Cancer
53%
Diseases
53%
Operation Duration
52%
Robot-Assisted Prostatectomy
48%
Pelvis
46%
Kidney Stone
45%
Kidney Tumour
44%
Biopsy Technique
42%
Bleeding
41%
Cystectomy
39%
Surgery
36%
Nephrectomy
36%
Pyeloplasty
34%
Histopathology
34%
Cancer
34%
Surgeon
33%
Prostate Specific Antigen
32%
Pheochromocytoma
32%
Transitional Cell Carcinoma
32%
Retroperitoneal Lymph Node Dissection
32%
Malignant Neoplasm
30%
Gleason Score
28%
Urogenital Tuberculosis
28%
Recurrent Disease
26%
Radical Nephrectomy
25%
Prospective Cohort Study
25%
Robot-Assisted Surgery
23%
Microhematuria
22%
Tertiary Care
21%
Urinary System
20%
Laparoscopic Surgery
20%
Partial Nephrectomy
19%
Transrectal Ultrasonography
18%
Transurethral Resection
18%
Germinoma
17%
Open Surgery
16%
Ureteropelvic Junction Obstruction
16%
Cancer Diagnosis
16%
microRNA
16%
Adrenalectomy
16%
Antioxidant
16%
Lithotripsy
16%
Heavy Metal
16%
Overall Survival
15%
Tyrosine-Kinase Inhibitor
14%
Parenchyma
14%
Keyphrases
Renal Cell Carcinoma
80%
Upper Tract Urothelial Carcinoma
67%
Tumor
49%
Prostate Cancer
47%
Bladder
46%
Operative Time
38%
Single-center Experience
34%
Robot-assisted Radical Prostatectomy
29%
Prostate Carcinoma
29%
Robotic Surgery
26%
Operative
26%
Renal Mass
26%
Blood Loss
26%
Prospective Cohort Study
25%
Retrospective Analysis
25%
Laparoscopic Partial Nephrectomy
24%
Robot-assisted Laparoscopic Radical Prostatectomy
24%
Pheochromocytoma
24%
Genitourinary Tuberculosis
24%
Percutaneous Nephrolithotomy
24%
Robotics
23%
Prostate-specific Antigen
23%
Upper Tract
22%
Gleason Score
21%
Tertiary Care Hospital
21%
Radical Nephrectomy
20%
Renal Tumor
19%
Hematuria
19%
Robot-assisted Laparoscopy
19%
Metastatic Renal Cell Carcinoma (mRCC)
18%
Chemotherapy
18%
Tuberculosis
18%
Kidney
17%
Adjuvant Therapy
17%
Malignancy
17%
Radical Cystectomy
17%
Open Surgery
16%
Laparoscopy
16%
Postoperative Outcomes
16%
Therapeutic Target
16%
Indian Experience
16%
MicroRNA
16%
Nephrocutaneous Fistula
16%
Pelvic Kidney
16%
Early Dynamics
16%
Dynamic Positron Emission Tomography
16%
Total Prostate-specific Antigen
16%
Laparoscopic Pyeloplasty
16%
Autophagy
16%
IgG4-related Disease (IgG4-RD)
16%